SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-051154
Filing Date
2023-10-02
Accepted
2023-10-02 16:31:47
Documents
13
Period of Report
2023-10-01
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K cmra-20231001.htm   iXBRL 8-K 66364
  Complete submission text file 0000950170-23-051154.txt   230703

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20231001_pre.xml EX-101.PRE 14886
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20231001_lab.xml EX-101.LAB 23251
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20231001.xsd EX-101.SCH 3387
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20231001_def.xml EX-101.DEF 14681
7 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20231001_htm.xml XML 6429
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 231300151
SIC: 2834 Pharmaceutical Preparations